e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Interstitial lung disease: clinical pathobiology and BAL
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Two different clinical forms of pulmonary langerhans cell granulomatosis
S. Bilen Hizel, D. Aydin, C. Gundogdu, L. Kutluay, I. Bernay, E. Gulhan, G. Cetin, S. Gundogdu, M. Camurdanoglu ()
Source:
Annual Congress 2002 - Interstitial lung disease: clinical pathobiology and BAL
Session:
Interstitial lung disease: clinical pathobiology and BAL
Session type:
Thematic Poster Session
Number:
2974
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bilen Hizel, D. Aydin, C. Gundogdu, L. Kutluay, I. Bernay, E. Gulhan, G. Cetin, S. Gundogdu, M. Camurdanoglu (). Two different clinical forms of pulmonary langerhans cell granulomatosis. Eur Respir J 2002; 20: Suppl. 38, 2974
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Related content which might interest you:
Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
Prognosis of pulmonary Langerhans' cell granulomatosis
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003
A case of Wegener granulomatosis that mimics metastatic pulmonary tumor and progresses with eosinophilia
Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis
Year: 2007
Bronchocentric granulomatosis and pulmonary tumourlet mimicking lung cancer
Source: Annual Congress 2008 - Various thoracic tumours and interesting cases
Year: 2008
Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Three distinct clinical presentations of the diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011
Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016
Investigation of granulomatous lung diseases in cases with granulomatosis ocular pathologies
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020
Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017
Necrotising sarcoid granulomatosis as a rare diferential diagnosis of pulmonary nodules
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020
Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017
Year: 2018
Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept